Truist Securities analyst Brandon King maintains Seacoast Banking (NASDAQ:SBCF) with a Buy and lowers the price target from $42 to $39.
Lisata Therapeutics Q3 EPS $(7.88) Down From $(1.74) YoY
Lisata Therapeutics (NASDAQ:LSTA) reported quarterly losses of $(7.88) per share. This is a 352.87 percent decrease over losses of $(1.74) per share from the same period last year.